Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

7.18
Delayed Data
As of 12:09pm ET
 +0.1372 / +1.95%
Today’s Change
6.15
Today|||52-Week Range
11.34
-20.25%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close7.04
Today’s open6.89
Day’s range6.89 - 7.24
Volume5,870
Average volume (3 months)29,044
Market cap$103.3M
Data as of 12:09pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+9.20%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+283.15%
P/E ratioNM
Price/Sales46.88
Price/Book5.11

Competitors

 Today’s
change
Today’s
% change
OPHTOphthotech Corp+0.01+0.38%
BLRXBioLine RX Ltd-0.00-0.01%
CPIXCumberland Pharmaceu...-0.03-0.44%
--EcoGreen Internation...-0.00-1.45%
Data as of 3:01pm ET, 04/20/2018

Financials

Last reporting dateApril 20, 2018
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$2.5M
Annual profit (last year)-$10.5M
Net profit margin-426.71%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, Jerusalem

Forecasts